ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0068

Unique Fibroblast-like Synoviocyte Phenotype with Elevated MCSF Expression Induced by TLR5 Activation in Rheumatoid Arthritis

Aryan Patel1, Osama Al Zoubi2 and Shiva Shahrara3, 1University of Illinois at Chicago, Chicago, 2University of Illinois at Chicago, Chicago, IL, 3University of Illinois, Chicago, IL

Meeting: ACR Convergence 2025

Keywords: Fibroblasts, Synovial, Inflammation, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0067–0097) Rheumatoid Arthritis – Etiology and Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1% of the global population, causing significant morbidity and disability. Fibroblast-like synoviocytes (FLS) are key effector cells in RA, contributing to inflammation and exhibiting invasive properties that facilitate joint damage. Despite extensive research, the underlying pathophysiology and immunometabolic dysregulation in RA remain incompletely understood.

Methods: This project aimed to investigate the immunometabolic reprogramming resulting from Toll-like receptor 5 (TLR5) pathway activation in RA FLS, uncovering cellular markers of reprogrammed FLS and exploring cellular crosstalk mechanisms between RA FLS and peripheral blood mononuclear cells (PBMCs). RA FLS were isolated from fresh synovial tissue and treated with flagellin (TLR5 ligand) or PBS (control) for 6 or 18 hours. Gene expression analysis was performed using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and RNA sequencing to assess the change in key inflammatory and cellular markers.

Results: TLR5-activated RA FLS exhibited a unique RSPO3^high/THY1^low signature, characterized by significantly higher expression of RSPO3 (RNA-seq Log2 FoldChange: 3.34, p< 0.0001; qPCR: Mean Fold Change: 7.370, p=0.016), while CD90 (THY1) expression remained unchanged (RNA-seq Log2 FoldChange: -0.16, p=0.15; qPCR: Mean Fold Change: 1.079, p=0.6276). This RSPO3/THY1 phenotype exhibited a significantly higher expression of IL-6 and CCL2, qPCR: 6.31 and 10.05, respectively, supporting its proinflammatory role in the RA joint environment. Additionally, this phenotype was associated with significantly increased expression of Macrophage colony-stimulating factor (MCSF/CSF1) (RNA-seq Log2 FoldChange: 1.84, p< 0.0001; qPCR: Mean Fold Change: 4.959, p=0.0080).

Conclusion: Publicly available single-cell RNA sequencing databases further revealed that CSF1 is almost exclusively expressed by fibroblasts, while CSF1R is nearly exclusively expressed by macrophages, indicating a paracrine axis of fibroblast–macrophage communication that may be central to inflammation and tissue remodeling in RA. This was in contrast to CSF2 and CSF3, which were not significantly expressed in RA FLS.In conclusion, we have identified a distinct RSPO3^high/THY1^low RA FLS phenotype with elevated CSF1 expression, suggesting a functionally reprogrammed subset of FLS with pro-inflammatory and pro-osteoclastogenic potential. RSPO3, a potent enhancer of Wnt signaling, has been previously reported to be upregulated in the synovium of RA patients and experimental arthritis models. Our study provides insights into the role of TLR5 in activating this invasive phenotype, which may play a crucial role in RA pathogenesis through CSF1-mediated interactions with macrophages, potentially influencing osteoclast differentiation. These findings enhance our understanding of RA pathophysiology and direct us to explore potential interventions to target this fibroblast subset.

Supporting image 1qPCR Data and Heat Map for Gene Markers

Supporting image 2Cell Locations and Heat Map Expression for Unique Phenotype and M-CSF

Supporting image 3Pathogenisis Diagram


Disclosures: A. Patel: None; O. Al Zoubi: None; S. Shahrara: None.

To cite this abstract in AMA style:

Patel A, Al Zoubi O, Shahrara S. Unique Fibroblast-like Synoviocyte Phenotype with Elevated MCSF Expression Induced by TLR5 Activation in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/unique-fibroblast-like-synoviocyte-phenotype-with-elevated-mcsf-expression-induced-by-tlr5-activation-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unique-fibroblast-like-synoviocyte-phenotype-with-elevated-mcsf-expression-induced-by-tlr5-activation-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology